Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative.

Autor: Koren, Jan¹ (AUTHOR), Lambert, Jo L. W.² (AUTHOR) jo.lambert@uzgent.be, Thomsen, Simon F.³ (AUTHOR), McAteer, Helen⁴ (AUTHOR), Fabbrocini, Gabriella⁵ (AUTHOR), Corazza, Valeria⁶ (AUTHOR), Jullien, Denis^7,8 (AUTHOR), Augustin, Matthias⁹ (AUTHOR), Warren, Richard B.¹⁰ (AUTHOR), de Rie, Menno A.¹¹ (AUTHOR), Lazaridou, Elizabeth¹² (AUTHOR), Puig, Lluís¹³ (AUTHOR), Guillevin, Loïc¹⁴ (AUTHOR), Grosser, Marius¹⁵ (AUTHOR), Boehncke, Wolf-Henning^16,17 (AUTHOR)

Publikováno v: Dermatology & Therapy. Jan2023, Vol. 13 Issue 1, p245-268. 24p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Additional file 1 of Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study

Autor: van der Schoot, Lara S., van den Reek, Juul M. P. A., Grine, Lynda, Schots, Lisa, Kievit, Wietske, Lambert, Jo L. W., de Jong, Elke M. G. J.

Additional file 1: Appendix 1. Model informed consent forms BeNeBio study.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e3a65eb355f26a602a778c308faf92c

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Disease severity in moderate‐to‐severe plaque psoriasis: Results from the Belgian REDISCOVER study.

Autor: Hillary, Tom¹ (AUTHOR), Ghys, Liesbeth F. E.² (AUTHOR) Liesbeth.Ghys@abbvie.com, Willaert, Fabienne³ (AUTHOR), Swimberghe, Sandra⁴ (AUTHOR), Lecuyer, Myriam⁴ (AUTHOR), Ghislain, Pierre‐Dominique⁵ (AUTHOR), Morrens, Joachim² (AUTHOR), Lambert, Jo L. W.⁶ (AUTHOR)

Publikováno v: JEADV Clinical Practice. Jul2024, p1. 12p. 5 Illustrations, 3 Charts.